Functional cardiac consequences of β-adrenergic stress-induced injury in the mouse model of Duchenne muscular dystrophy

Conner C. Earl,Areli J. Javier,Alyssa M. Richards,Larry W. Markham,Craig J. Goergen,Steven S. Welc

DOI: https://doi.org/10.1101/2024.04.15.589650

2024-04-20

Abstract:Cardiomyopathy is the leading cause of death in Duchenne muscular dystrophy (DMD), however, in the mouse model of DMD, the cardiac phenotype differs from that seen in DMD-associated cardiomyopathy. Although some have used pharmacologic stress to enhance the cardiac phenotype in the model, many methods lead to high mortality, variable cardiac outcomes, and do not recapitulate the structural and functional cardiac changes seen in human disease. Here, we describe a simple and effective method to enhance the cardiac phenotype model in mice using advanced 2D and 4D high-frequency ultrasound to monitor cardiac dysfunction progression . For our study, and wild-type (WT) mice received daily low-dose (2 mg/kg/day) isoproterenol injections for 10 days. Histopathologic assessment showed that isoproterenol treatment increased myocyte injury, elevated serum cardiac troponin I levels, and enhanced fibrosis in mice. Ultrasound revealed reduced ventricular function, decreased wall thickness, increased volumes, and diminished cardiac reserve in mdx mice compared to wild-type. Our findings highlight the utility of low-dose isoproterenol in mice as a valuable model for exploring therapies targeting DMD-associated cardiac complications.

Physiology